Sponsor:
Methodist Health System
Code:
NCT05944042
Conditions
Identify More Accurate Predictive Models of Transplant Risk to Monitor and Evaluate New and Existing Patient Factors
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Accepted
Interventions
Observational Transplant Analysis
Brief summary:
Conditions
Identify More Accurate Predictive Models of Transplant Risk to Monitor and Evaluate New and Existing Patient Factors
Study ID
NCT05944042
Start date
Feb 1, 2023
Status verified date
Jan, 2024
Completion date
Feb 2, 2025
Anticipated
Primary completion date
Feb 2, 2025
Anticipated
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Accepted
Enrollment
300 participants
Anticipated
Arms
Intra-Operative Data:
Post-Operative Data and Follow-Up:
Interventions
Observational Transplant Analysis
Primary outcome measure
Central contacts
Locations
Methodist Dallas Medical Center
Recruiting
Dallas, Texas, United States, 75203
Contacts
Principal Investigator:
Alejandro Mejia, MD
Sponsor
Methodist Health System
Last update posted
Mar 27, 2024
Last verified
Jan, 2024
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Methodist Health System on 2024-03-27.